Miyamoto T - Search Results

1

[Hematopoietic stem cells are primarily involved in pathogenesis of chronic lymphocytic leukemia].

Kikushige Y, Miyamoto T, Akashi K. Kikushige Y, et al. Among authors: miyamoto t. Rinsho Ketsueki. 2010 Aug;51(8):679-84. Rinsho Ketsueki. 2010. PMID: 20805675 Review. Japanese. No abstract available.

2

Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesis.

Kikushige Y, Miyamoto T. Kikushige Y, et al. Among authors: miyamoto t. Int J Hematol. 2014 Oct;100(4):335-40. doi: 10.1007/s12185-014-1651-6. Epub 2014 Aug 7. Int J Hematol. 2014. PMID: 25100497 Review.

3

Pre-malignant lymphoid cells arise from hematopoietic stem/progenitor cells in chronic lymphocytic leukemia.

Kikushige Y, Miyamoto T. Kikushige Y, et al. Among authors: miyamoto t. Int J Hematol. 2015 Nov;102(5):528-35. doi: 10.1007/s12185-015-1740-1. Epub 2015 Feb 3. Int J Hematol. 2015. PMID: 25644149 Review.

4

[Progress in the leukemic stem cell study and a novel therapeutic approach targeting leukemic stem cells].

Kikushige Y, Miyamoto T, Akashi K. Kikushige Y, et al. Among authors: miyamoto t. Rinsho Ketsueki. 2017;58(10):1838-1843. doi: 10.11406/rinketsu.58.1838. Rinsho Ketsueki. 2017. PMID: 28978822 Japanese.

5

[Specific surface markers of AML-leukemic stem cells].

Kikushige Y, Miyamoto T, Akashi K. Kikushige Y, et al. Among authors: miyamoto t. Rinsho Ketsueki. 2011 Jul;52(7):531-4. Rinsho Ketsueki. 2011. PMID: 21821985 Review. Japanese. No abstract available.

6

Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia.

Kikushige Y, Ishikawa F, Miyamoto T, Shima T, Urata S, Yoshimoto G, Mori Y, Iino T, Yamauchi T, Eto T, Niiro H, Iwasaki H, Takenaka K, Akashi K. Kikushige Y, et al. Among authors: miyamoto t. Cancer Cell. 2011 Aug 16;20(2):246-59. doi: 10.1016/j.ccr.2011.06.029. Cancer Cell. 2011. PMID: 21840488 Free article.

7

[Clinical outcomes of allogeneic hematopoietic stem cell transplantation for adult primary myelofibrosis: retrospective analysis by Fukuoka BMT group].

Kamimura T, Yong C, Ito Y, Henzan H, Miyamoto T, Ohno Y, Eto T, Takenaka K, Akashi K. Kamimura T, et al. Among authors: miyamoto t. Rinsho Ketsueki. 2012 Mar;53(3):323-8. Rinsho Ketsueki. 2012. PMID: 22499049 Review. Japanese.

8

TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells.

Kikushige Y, Miyamoto T. Kikushige Y, et al. Among authors: miyamoto t. Int J Hematol. 2013 Dec;98(6):627-33. doi: 10.1007/s12185-013-1433-6. Epub 2013 Sep 18. Int J Hematol. 2013. PMID: 24046178 Review.

9

[Frontline treatment of AML in adults].

Miyamoto T, Kikushige Y, Yoshimoto AG. Miyamoto T, et al. Rinsho Ketsueki. 2017;58(10):1884-1894. doi: 10.11406/rinketsu.58.1884. Rinsho Ketsueki. 2017. PMID: 28978829 Japanese.

10

[Cytotoxic chemotherapy for AML in adults].

Miyamoto T, Kikushige Y. Miyamoto T, et al. Rinsho Ketsueki. 2020;61(9):1138-1149. doi: 10.11406/rinketsu.61.1138. Rinsho Ketsueki. 2020. PMID: 33162509 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,204 results

Search Page

Filters